文献速递肿瘤 PET/CT

18F-氟胆碱PET/CT偶然检出早期声门上喉原位鳞状细胞癌

Early-Stage Supraglottic "In Situ" Squamous Cell Carcinoma of the Larynx Incidentally Detected by 18F-Fluorocholine PET/CT.
PubMed 文献 · Clin Nucl Med · 2019-01-01

本文报道一例前列腺癌患者在18F-氟胆碱(F-FCH)PET/CT检查中偶然检出喉部鳞状细胞癌的病例。F-FCH因可评估细胞增殖而并非肿瘤特异,多种肿瘤均可摄取,既可能扩展成像机会,也可能成为图像判读的误差来源。

要点

  • F-FCH PET/CT除前列腺癌外,还可被多发性骨髓瘤、淋巴瘤、肺癌、膀胱癌、结肠癌等摄取。
  • F-FCH摄取反映细胞增殖,可导致图像判读误差。
  • 本病例为F-FCH PET/CT偶然发现的喉鳞状细胞癌。

核心结论

  • F-FCH PET/CT在前列腺癌评估中可偶然检出喉鳞状细胞癌,提示其非肿瘤特异性摄取具有诊断机会与误判风险并存的特点。

研究设计与样本

  • 本文为病例报告,报道一例经F-FCH PET/CT检出的喉鳞状细胞癌病例。

主要发现

  • F-FCH可被多发性骨髓瘤、淋巴瘤、肺癌、膀胱癌、结肠癌、脑肿瘤、肾细胞癌和肝细胞癌摄取。
  • F-FCH的摄取机制与评估细胞增殖有关,而细胞增殖为肿瘤细胞的典型特征。

临床怎么用

  • 阅读F-FCH PET/CT时需注意前列腺癌以外的其他肿瘤也可能摄取F-FCH,避免漏诊或误判。

局限性

  • 本文为单例病例报告,未提供样本量、灵敏度、特异度或阈值等定量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

F-fluorocholine (F-FCH) PET/CT is widely used to study patients affected by prostate cancer. Despite its specificity, however, F-FCH may be taken up by other neoplasms such as multiple myeloma, lymphomas, lung, bladder, and colon cancer; brain tumors; and renal and hepatocellular carcinoma. This is due to its ability to evaluate the cell proliferation, which is typical of neoplastic cells. While this behavior may be an opportunity to image more neoplasms, on the other hand it could represent a source of error in the evaluation of the images. Here we present the case of a laryngeal squamous cell carcinoma detected by F-FCH.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Mangili SA, Rizzardi N, Illuminati S, et al. Early-Stage Supraglottic "In Situ" Squamous Cell Carcinoma of the Larynx Incidentally Detected by 18F-Fluorocholine PET/CT. Clin Nucl Med. 2019. PMID: 31058692. doi:10.1097/RLU.0000000000002596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。